Dragana Nikolic
Overview
Explore the profile of Dragana Nikolic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
86
Citations
1761
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gnocchi D, Nikolic D, Russo S, Matrella M, Paparella R, Kumar S, et al.
Am J Physiol Cell Physiol
. 2025 Jan;
PMID: 39853268
Resistance to drugs is one of the major issues affecting the response to pharmacological treatments for tumors. Different mechanisms have been proposed to explain the development of cancer drug resistance...
2.
Banovic deri B, Nesic S, Vicic I, Samardzic J, Nikolic D
Front Microbiol
. 2024 Aug;
15:1401985.
PMID: 39101033
Advances in small RNAs (sRNAs)-related studies have posed a challenge for NGS-related bioinformatics, especially regarding the correct mapping of sRNAs. Depending on the algorithms and scoring matrices on which they...
3.
Gnocchi D, Nikolic D, Paparella R, Sabba C, Mazzocca A
Plant Foods Hum Nutr
. 2024 May;
79(2):417-424.
PMID: 38710924
Hepatocellular carcinoma (HCC) is an alarming epidemiological clinical problem worldwide. Pharmacological approaches currently available do not provide adequate responses due to poor effectiveness, high toxicity, and serious side effects. Our...
4.
Gnocchi D, Nikolic D, Castellaneta F, Paparella R, Sabba C, Mazzocca A
Am J Physiol Cell Physiol
. 2023 Nov;
325(6):C1431-C1438.
PMID: 37927240
After decades of focus on molecular genetics in cancer research, the role of metabolic and environmental factors is being reassessed. Here, we investigated the role of microenvironment in the promotion...
5.
Gnocchi D, Nikolic D, Paparella R, Sabba C, Mazzocca A
Cancers (Basel)
. 2023 Aug;
15(15).
PMID: 37568758
Adaptation of cancer cells to extreme microenvironmental conditions (i.e., hypoxia, high acidity, and reduced nutrient availability) contributes to cancer resilience. Furthermore, neoplastic transformation can be envisioned as an extreme adaptive...
6.
Nikolic D, Bosnic D, Samardzic J
Front Plant Sci
. 2023 Feb;
14:1039053.
PMID: 36818840
Essential micronutrients belonging to the transition metals, such as Fe and Cu, are indispensable for plant growth and stress tolerance; however, when present in excess, they can become potentially dangerous...
7.
Terzo S, Amato A, Magan-Fernandez A, Castellino G, Calvi P, Chianetta R, et al.
Nutrients
. 2023 Jan;
15(2).
PMID: 36678333
Pre-obesity is a condition that predisposes to the risk of developing obesity, cardiovascular diseases (CVD), and diabetes. Our previous study demonstrated that a Cynara cardunculus (L.) based nutraceutical named Altilix®...
8.
Nikolic D, Bosco L, Moschetti M, Tinnirello V, Pucci M, Corleone V, et al.
J Food Sci
. 2023 Jan;
88(3):1172-1187.
PMID: 36651875
Chronic inflammation is linked to the development of numerous diseases and is accompanied by increased cytokine secretion. Macrophages provide a first line of defense against pathogens that under inflammatory stimuli...
9.
Nikolic D, Patti A, Giglio R, Chianetta R, Castellino G, Magan-Fernandez A, et al.
Diabetes Ther
. 2022 Feb;
13(3):453-464.
PMID: 35167051
Introduction: The glucagon-like peptide-1 agonist (GLP1-RA) liraglutide is currently approved for the treatment of both obesity and type 2 diabetes (T2DM). We investigated whether the effect of this agent on...
10.
Banerjee Y, Pantea Stoian A, Cicero A, Fogacci F, Nikolic D, Sachinidis A, et al.
Expert Opin Drug Saf
. 2021 Oct;
21(1):9-20.
PMID: 34596005
Introduction: Inclisiran is a novel posttranscriptional gene silencing therapy that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9) synthesis by RNA interference and has a potent, dose-dependent, durable effect in lowering...